檢索結果 - Asad Bashey

Refine Results
  1. 1
    Proliferative but not nonproliferative responses to granulocyte colony- stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway

    Proliferative but not nonproliferative responses to granulocyte colony- stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway 由 Asad Bashey, Lyn Healy, C. J. Marshall

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation

    Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood... 由 Scott R. Solomon, Melissa Sanacore, Xu Zhang, Stacey Brown, Kent Holland, Lawrence E. Morris, Asad Bashey

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center

    Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center 由 Melhem Solh, Xu Zhang, Katelin Connor, Stacey Brown, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Asad Bashey

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

    Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventi... 由 Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore, Xu Zhang, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Asad Bashey

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors

    Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Match... 由 Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore, Xu Zhang, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Asad Bashey

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

    T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of... 由 Asad Bashey, Xu Zhang, Connie A. Sizemore, Karen Manion, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Scott R. Solomon

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index

    Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -D... 由 Asad Bashey, Xu Zhang, Katelin C Jackson, Stacey Brown, Michelle Ridgeway, Melhem Solh, Lawrence E. Morris, H. Kent Holland, Scott R. Solomon

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older

    Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patient... 由 Zain Bashey, Xu Zhang, Stacey Brown, Katelin C Jackson, Lawrence E. Morris, H. Kent Holland, Asad Bashey, Scott R. Solomon, Melhem Solh

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis

    HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis 由 Mohamad Aghaie Meybodi, Wenhao Cao, Leo Luznik, Asad Bashey, Xu Zhang, Rizwan Romee, Wael Saber, Mehdi Hamadani, Daniel J. Weisdorf, Haitao Chu, Armin Rashidi

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells

    CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells 由 Jiehua Zhou, Asad Bashey, Rui‐kun Zhong, Sue Corringham, Karen Messer, Minya Pu, Wenxue Ma, Theresa Chut, Robert J. Soiffer, Rachel Mitrovich, Israel Lowy, Edward D. Ball

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables

    Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables 由 Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Allison Piluso, Brian M. Freed, Stacey Brown, Katelin C Jackson, Lawrence E. Morris, H. Kent Holland, Melhem Solh, Asad Bashey

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study

    Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Ant... 由 Farhad Ravandi, Asad Bashey, Wendy Stock, James M. Foran, Raya Mawad, Daniel Egan, William Blum, Allen S. Yang, A. Pastore, Chelsea Johnson, Shuo Zheng, Musa Yılmaz, Alice S. Mims

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901

    Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901 由 Thomas C. Shea, Jeffrey L. Johnson, Peter Westervelt, Sherif S. Farag, John M. McCarty, Asad Bashey, Luis Isola, Lee-Anne Baxter-Lowe, Michael E. Kelly, Kouros Owzar, Charles Linker

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study

    Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial... 由 Farhad Ravandi, Asad Bashey, James M. Foran, Wendy Stock, Raya Mawad, William Blum, M. Wayne Saville, Chelsea Johnson, K. Gary J. Vanasse, Thomas Ly, Hagop M. Kantarjian, Bhavana Bhatnagar, Koichi Takahashi, Alice S. Mims

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

    CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation 由 Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Linda Vrooman, Israel Lowy, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, James R. Mason, Edwin P. Alyea, Robert J. Soiffer, Edward D. Ball

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia

    Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia 由 Samer A. Srour, Denái R. Milton, Asad Bashey, Amado Karduss, Monzr M. Al Malki, Rizwan Romee, Scott R. Solomon, Auayporn Nademanee, Stacey Brown, Michael Slade, Rosendo Lurı́a-Pérez, Gabriela Rondón, Stephen J. Forman, Richard E. Champlin, Partow Kebriaei, Stefan O. Ciurea

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

    Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study 由 Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, Michael Ozga, Anurag K. Singh, Sameem Abedin, Amy E. DeZern, Richard J. Jones, Vikas Gupta, Aaron T. Gerds, Tania Jain

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia

    Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia 由 Farhad Ravandi, Asad Bashey, James M. Foran, Wendy Stock, Raya Mawad, Nicholas J. Short, Musa Yılmaz, Hagop M. Kantarjian, Olatoyosi Odenike, Anand Patel, Raman Garcha, William B. Ainsworth, Raphael Clynes, Jitendra Kanodia, Ying Ding, Huajiang Li, Steve Kye, Alice S. Mims

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide 由 Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel‐Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Álvaro Urbano-Ispízua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

    Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) 由 HM Lazarus, FR Loberiza, M-J Zhang, JO Armitage, KK Ballen, Asad Bashey, BJ Bolwell, LJ Burns, CO Freytes, RP Gale, John Gibson, RH Herzig, CF LeMaistre, D I Marks, J. D. Mason, AM Miller, GA Milone, S Pavlovsky, DE Reece, JD Rizzo, Koen van Besien, JM Vose, MM Horowitz

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: